Heartstream Emerges as a Leader in Emergency Medical Care Solutions

Heartstream Launches as an Independent Emergency Care Leader

On January 14, 2026, Heartstream officially launched as an independent entity within Emergency Care Holdings (ECH), marking a significant milestone in the emergency medical care sector. The company was formed through the acquisition of the Philips Emergency Care business, part of Royal Philips, and brings a renewed focus on developing life-saving technologies aimed at improving survival rates for cardiac arrest victims worldwide.

Having a legacy that spans over a century, Heartstream has continuously innovated within the emergency medical field. It aims to leverage this extensive experience to enhance cardiac arrest survival rates, optimize clinical outcomes, and ease the financial burdens that health systems face. "At Heartstream, we are dedicated to not only saving lives but making the processes surrounding emergency care as seamless as possible for first responders and healthcare providers," stated Ryan Landon, CEO of Heartstream.

A Legacy of Innovation

Heartstream's journey is steeped in significant milestones, including the development of the first automated external defibrillator (AED) and pioneering various cardiac monitoring solutions. The company emerged from a rich history of technological advances associated with respected names like Hewlett-Packard, Agilent Technologies, and Royal Philips. Their contributions have been instrumental in establishing industry standards, such as the first 12-lead ECG algorithm and the first biphasic defibrillation waveform, which remains a key feature in modern defibrillators today.

Currently, the Heartstream portfolio includes renowned emergency care devices, such as the HeartStart AED and advanced patient monitoring systems like Tempus and Intrepid. Under a multi-year licensing agreement, Heartstream will still operate under the Philips brand, ensuring continuity and reliability in the eyes of both professionals and the public.

Addressing Public Health Challenges

Sudden cardiac arrest presents one of the most significant public health challenges globally. Research from the American Heart Association reveals that nearly 72% of cardiac arrests occur outside of hospital settings, with survival rates lingering below 10%. Alarmingly, less than 1% of households currently possess a defibrillator, underscoring a critical need for improvement in accessibility to emergency medical equipment.

In light of these challenges, Heartstream is committed to expanding the availability of AEDs in various settings, including public spaces and homes. The company intends to strengthen its global footprint with better supply chain strategies, enhanced digital solutions, and increased engagement with strategic distributors. Focusing on customer-centric innovation, Heartstream seeks to develop comprehensive support and educational programs that empower individuals to respond effectively in emergencies.

The Future of Emergency Care

Being a part of ECH provides Heartstream with the resources and strategic direction necessary to propel its mission forward. ECH's commitment to bolstering operations and innovation equips Heartstream to lead advancements in emergency medical care effectively.

Landon emphasized, "At the heart of our operations lies a profound respect for all those who depend on our innovations — including patients, healthcare practitioners, and the everyday heroes ready to step in during emergencies. We are passionate about our work and the positive impact it has on lives."

In summary, Heartstream emerges not just as a company, but as a paradigm shift in the approach to emergency medical solutions, harnessing decades of expertise and modern technology to save lives when it matters most. With a sharp focus on accessibility, reliability, and efficiency, it stands poised to enhance the emergency care landscape for years to come.

For more information, visit Heartstream's official website.

About Emergency Care Holdings

Emergency Care Holdings was established by Bridgefield Capital to amass and develop top-tier companies within the emergency medical products segment. By concentrating on improving operations and accelerating innovation, ECH aims to broaden access to vital, life-saving technologies utilized worldwide.